Bluejay Diagnostics (BJDX) Cash from Operations (2020 - 2026)

Bluejay Diagnostics (BJDX) has 7 years of Cash from Operations data on file, last reported at 1589200.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 34.13% year-over-year to 1589200.0; the trailing twelve-month figure through Mar 2026 stood at 6457918.0 (up 3.7% YoY), and the FY2025 full-year result was 6053575.0, up 22.6% from the prior year.
• Cash from Operations retreated to 1589200.0 in Q1 2026, from 1454870.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 1125066.0 in Q3 2023 to a low of 2944243.0 in Q4 2022.
• A 5-year average of 1854062.35 and a median of 1659062.0 in 2022 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations slumped 403.8% in 2022 and jumped 48.48% in 2025, its largest moves.
• Tracing BJDX's Cash from Operations over 5 years: stood at 2944243.0 in 2022, then gained by 5.66% to 2777477.0 in 2023, then jumped by 47.75% to 1451345.0 in 2024, then dropped by 0.24% to 1454870.0 in 2025, then declined by 9.23% to 1589200.0 in 2026.
• Business Quant data shows BJDX's Cash from Operations at 1589200.0 in Q1 2026, 1454870.0 in Q4 2025, and 1359793.0 in Q3 2025.